cyclophosphamide injection
dr. reddy's laboratories inc. - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide anhydrous - unii:6uxw23996m) - malignant diseases cyclophosphamide injection is indicated for the treatment of adult and pediatric patients with: - malignant lymphomas (stages iii and iv of the ann arbor staging system), hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma burkitt’s lymphoma - multiple myeloma · - leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) - mycosis fungoides (advanced disease) - neuroblastoma (disseminated disease) - adenocarcinoma of the ovary - retinoblastoma - carcinoma of the breast cyclophosphamide injection, although effective alone in susceptible malignancies, is more frequently used concurrently or sequentially with other antineoplastic drugs. hypersensitivity cyclophosphamide injection is contraindicated in pat
x cyclophosphamide powder
ax pharmaceutical corp - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide anhydrous - unii:6uxw23996m) - cyclophosphamide anhydrous 495 g in 500 g
x cyclophosphamide powder
ax pharmaceutical corp - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide anhydrous - unii:6uxw23996m) - cyclophosphamide anhydrous 99 g in 100 g
cyclophosphamide powder
bluebay shandong co.,ltd - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide - unii:8n3dw7272p) -
endoxan for injection 1 gvial
baxter healthcare (asia) pte ltd - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous - injection, powder, for solution - 1 g/vial - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous 1 g/vial
endoxan for injection 200 mgvial
baxter healthcare (asia) pte ltd - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous - injection, powder, for solution - 200 mg/vial - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous 200 mg/vial
cyclophosphamide 50mg tablets
a a h pharmaceuticals ltd - cyclophosphamide monohydrate - oral tablet - 50mg
cyclophosphamide 50mg tablets
pfizer ltd - cyclophosphamide monohydrate - oral tablet - 50mg
cyclophosphamide 50mg tablets
alliance healthcare (distribution) ltd - cyclophosphamide monohydrate - oral tablet - 50mg
cyclophosphamide 50mg tablets
cst pharma ltd - cyclophosphamide monohydrate - oral tablet - 50mg